5.555
0.27%
0.015
前日終値:
$5.54
開ける:
$5.5
24時間の取引高:
1.23M
Relative Volume:
0.33
時価総額:
$1.31B
収益:
$251.85M
当期純損益:
$-72.58M
株価収益率:
-46.29
EPS:
-0.12
ネットキャッシュフロー:
$-63.80M
1週間 パフォーマンス:
+3.83%
1か月 パフォーマンス:
-8.78%
6か月 パフォーマンス:
-19.73%
1年 パフォーマンス:
+16.70%
Ardelyx Inc Stock (ARDX) Company Profile
ARDX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
5.56 | 1.31B | 251.85M | -72.58M | -63.80M | -0.3134 |
VRTX
Vertex Pharmaceuticals Inc
|
461.00 | 119.71B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
752.71 | 82.77B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
616.63 | 37.02B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
251.43 | 32.26B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
117.19 | 28.24B | 3.30B | -501.07M | 1.03B | -2.1146 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-11-11 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2024-07-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
2024-04-05 | 開始されました | Leerink Partners | Outperform |
2023-12-18 | 開始されました | Raymond James | Strong Buy |
2023-09-07 | 開始されました | H.C. Wainwright | Buy |
2023-08-25 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
2023-03-03 | アップグレード | Wedbush | Neutral → Outperform |
2022-11-17 | アップグレード | Piper Sandler | Neutral → Overweight |
2022-05-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
2021-12-01 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
2021-10-14 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
2021-07-21 | ダウングレード | Jefferies | Buy → Hold |
2021-07-20 | ダウングレード | Piper Sandler | Overweight → Neutral |
2021-07-20 | ダウングレード | Wedbush | Outperform → Neutral |
2021-03-23 | 開始されました | Wedbush | Outperform |
2021-01-06 | 開始されました | Cantor Fitzgerald | Overweight |
2020-10-20 | 再開されました | Citigroup | Buy |
2020-02-18 | 再開されました | Jefferies | Buy |
2020-02-12 | 開始されました | Citigroup | Buy |
2020-02-10 | 開始されました | Cowen | Outperform |
2019-04-08 | 開始されました | Piper Jaffray | Overweight |
2018-08-24 | 開始されました | Jefferies | Buy |
2018-03-19 | 再開されました | Leerink Partners | Outperform |
2017-11-29 | 繰り返されました | Citigroup | Buy |
2017-11-22 | 繰り返されました | Ladenburg Thalmann | Buy |
2017-10-17 | 再開されました | Leerink Partners | Outperform |
2016-03-31 | 開始されました | Ladenburg Thalmann | Buy |
2016-03-09 | 開始されました | Cantor Fitzgerald | Buy |
2016-03-03 | 開始されました | Citigroup | Buy |
すべてを表示
Ardelyx Inc (ARDX) 最新ニュース
Eventide Asset Management LLC Boosts Stock Holdings in Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
Long Term Trading Analysis for (ARDX) - Stock Traders Daily
Vestal Point Capital LP Acquires Shares of 500,000 Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
Ardelyx CEO Michael Raab sells $134,482 in stock By Investing.com - Investing.com Nigeria
Ardelyx CEO Michael Raab sells $134,482 in stock - Investing.com
Rubric Capital Management LP Raises Stock Holdings in Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
Propel Bio Management LLC Purchases 146,364 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
Ardelyx Lost The Lawsuit, But The Kidney PATIENT Act Will Save It (NASDAQ:ARDX) - Seeking Alpha
Principal Financial Group Inc. Sells 336,014 Shares of Ardelyx, Inc. (NASDAQ:ARDX) - MarketBeat
Insider Selling: Ardelyx, Inc. (NASDAQ:ARDX) CEO Sells 31,980 Shares of Stock - MarketBeat
Ardelyx's regulatory officer sells $23,689 in stock By Investing.com - Investing.com Australia
Ardelyx CEO Michael Raab sells $153,328 in common stock - Investing.com India
Ardelyx CEO Michael Raab sells $153,328 in common stock By Investing.com - Investing.com Australia
Ardelyx executive sells $33,782 in stock - Investing.com India
Ardelyx executive sells $33,782 in stock By Investing.com - Investing.com South Africa
Ardelyx, Inc. (NASDAQ:ARDX) CFO Sells $25,195.40 in Stock - MarketBeat
Ardelyx's regulatory officer sells $23,689 in stock - Investing.com India
Ardelyx, Inc. (NASDAQ:ARDX) Insider Laura A. Williams Sells 7,366 Shares - MarketBeat
Ardelyx chief development officer sells $34,443 in stock By Investing.com - Investing.com Nigeria
Ardelyx chief medical officer sells $35,316 in stock By Investing.com - Investing.com Nigeria
Ardelyx chief development officer sells $34,443 in stock - Investing.com India
Ardelyx CFO Justin Renz sells $25,219 in stock By Investing.com - Investing.com South Africa
Ardelyx CFO Justin Renz sells $25,219 in stock - Investing.com India
Ardelyx chief medical officer sells $35,316 in stock - Investing.com India
Ardelyx Independent Chairman of the Board Acquires 18% More Stock - Simply Wall St
Ardelyx, Inc Announces Executive Changes - Marketscreener.com
Shareholders of Ardelyx, Inc. Should Contact The Gross Law Firm - GuruFocus.com
Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for InvestorsContact Levi & Korsinsky - GuruFocus.com
ARDX Investors Have Opportunity to Lead Ardelyx, Inc.Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus.com
Ardelyx, Inc. Sued for Securities Law ViolationsContact the D - GuruFocus.com
Ardelyx down as H.C. Wainwright downgrades rating on anticipated Xphozah sales drop - MSN
Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
Ardelyx Executives to Present at Piper Sandler Healthcare Conference | ARDX Stock News - StockTitan
Jefferies optimistic on Ardelyx stock as management navigates reimbursement changes - Investing.com
High Growth Tech Stocks To Explore In November 2024 - Yahoo Finance
Ardelyx appoints new principal accounting officer - Investing.com
US Penny Stocks To Monitor In November 2024 - Simply Wall St
Ardelyx, Inc. (NASDAQ:ARDX) Short Interest Up 5.1% in October - MarketBeat
Ardelyx, Inc. (NASDAQ:ARDX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Ardelyx (NASDAQ:ARDX) Shares Gap UpTime to Buy? - MarketBeat
Janus Henderson Group PLC's Strategic Reduction in Ardelyx Inc H - GuruFocus.com
Director David Mott Acquires 215,868 Shares of Ardelyx Inc (ARDX) - GuruFocus.com
Ardelyx's Medicare Setback Casts Doubt On Long-Term Viability (NASDAQ:ARDX) - Seeking Alpha
HC Wainwright Has Bearish Forecast for Ardelyx Q1 Earnings - MarketBeat
Ardelyx (NASDAQ:ARDX) Rating Lowered to “Neutral” at HC Wainwright - Defense World
Ardelyx shares downgraded amid sales concerns for XPHOZAH By Investing.com - Investing.com Australia
Ardelyx (NASDAQ:ARDX) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Ardelyx shares downgraded amid sales concerns for XPHOZAH - Investing.com India
Ardelyx (NASDAQ:ARDX) Lowered to Neutral Rating by HC Wainwright - MarketBeat
Ardelyx chief development officer sells shares worth $165,743 - Investing.com India
Ardelyx Inc (ARDX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):